The DayOne Accelerator has helped launch more than 75 innovative healthtech ventures since we started operating in 2018. You can find details of all our active alumni companies below.
Latest update: 01/09/2026
Portfolio
In the spotlight
Oncoustics
Oncoustics applies AI to raw sound signals on low-cost ultrasound devices turning these into powerful virtual biopsy tools that will democratize diagnostics.
FindMeCure / Trialhub
TrialHub: Insights that turn trials into treatments.
Theremia
Theremia is an AI-driven platform that optimizes drug development by ensuring pharmaceutical companies create the right drug for the right population subgroups.
Risklick
Revolutionizing clinical trial protocol with first-in-class AI software.
Senseera Health
Senseera’s goal is to transform precision medicine for every patient and pioneer liver diagnostics through groundbreaking chromatin epigenomics.
Portfolio
Company
Therapeutic areas
Country
Funding Stage
Development stage
epHealth
Therapeutic area: Cardiovascular diseases, Chronic diseases, Hypertension, Infectious diseases, Metabolic Diseases, Oncology, Rare Disease, Respiratory Diseases
Country: United Kingdom
Funding Stage: Seed
Development stage: Clinical evaluation
Mobile-first, end-to-end clinical trial platform integrating patients, sites and coordinating centers.
Visit website
Cardiovascular diseases, Chronic diseases, Hypertension, Infectious diseases, Metabolic Diseases, Oncology, Rare Disease, Respiratory Diseases
United Kingdom
Seed
Clinical evaluation
Ephion health
Therapeutic area: Chronic diseases, Rare Disease, Rehabilitation
Country: Spain
Funding Stage: Seed
Development stage: Commercial launch
AI-powered digital biomarkers from wearable gait data to monitor chronic disease progression.
Visit website
Chronic diseases, Rare Disease, Rehabilitation
Spain
Seed
Commercial launch
Eupnoos
Therapeutic area: Cardiovascular, Oncology, Pulmonology, Women's health
Country: United Kingdom
Funding Stage: Pre seed
Development stage: Clinical evaluation
Breath-test platform monitoring cardiopulmonary function to detect adverse events earlier during clinical trials.
Visit website
Cardiovascular, Oncology, Pulmonology, Women's health
United Kingdom
Pre seed
Clinical evaluation
Eviive
Therapeutic area: Dermatology, Hematology, Immunology, Oncology
Country: Switzerland
Funding Stage: Pre seed
Development stage: Clinical evaluation
Liquid biopsy diagnostics using single EV biomarkers to guide personalized cancer immunotherapy decisions.
Visit website
Dermatology, Hematology, Immunology, Oncology
Switzerland
Pre seed
Clinical evaluation
Exploris Health
Therapeutic area: Cardiovascular diseases, Oncology
Country: Switzerland
Funding Stage: Serie A
Development stage: Commercial launch
AI-based cardiac diagnostics like Cardio Explorer to detect and manage heart disease.
Visit website
Cardiovascular diseases, Oncology
Switzerland
Serie A
Commercial launch
FindMeCure / TrialHub
Therapeutic area: Autoimmune diseases, Oncology, Rare Disease
Country: United Kingdom
Funding Stage: Serie A
Development stage: Commercial launch
AI-powered data intelligence platform for clinical trial strategists to plan patient-centric studies.
Visit website
Autoimmune diseases, Oncology, Rare Disease
United Kingdom
Serie A
Commercial launch
Grove AI
Therapeutic area: Disease-agnostic
Country: United States
Funding Stage: Aquired
Development stage: Commercial launch
AI “digital staff” that automates clinical trial recruitment, participant engagement and site workflows.
Visit website
Disease-agnostic
United States
Aquired
Commercial launch
Harmonic Discovery
Therapeutic area: Disease-agnostic, Hematology, Oncology
Country: Finland
Funding Stage: Seed
Development stage: Preclinical research & prototyping
Machine learning–driven drug discovery platform designing multi-target kinase therapeutics with precision pharmacology.
Visit website
Disease-agnostic, Hematology, Oncology
Finland
Seed
Preclinical research & prototyping
Hemetron
Therapeutic area: Autoimmune diseases, Chronic diseases
Country: Switzerland
Funding Stage: Seed
Development stage: Design & development
At-home quantitative blood testing for inflammation to remotely monitor and optimize treatments.
Visit website
Autoimmune diseases, Chronic diseases
Switzerland
Seed
Design & development
Hope Care
Therapeutic area: Cardiovascular diseases, Chronic diseases, Pulmonology
Country: Portugal
Funding Stage: Serie A
Development stage: Commercial launch
Digital health solutions for remote patient monitoring and hospital-at-home care.
Visit website
Cardiovascular diseases, Chronic diseases, Pulmonology
Portugal
Serie A
Commercial launch
